Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Ketorolac Tromethamine

These are related to the Ketorolac Tromethamine news, in which you can learn about the updated information in Ketorolac Tromethamine, to help you better understand and expand Ketorolac Tromethamine market. Because the market for Ketorolac Tromethamine is evolving and changing, so we recommend that you collect our website, and we will show you the latest news on a regular basis.
  • Drug Patent & Exclusivity Expiration Report - Week of Nov 25 2024

    Drug Patent & Exclusivity Expiration Report - Week of Nov 25 2024

    2024-11-25

    This week, there are 3 drugs in the patent and exclusivity list. They are: - ABBVIE INC's ACULAR LS, containing active ingredient KETOROLAC TROMETHAMINE - FRESENIUS KABI USA LLC's DIPRIVAN, containing active ingredient PROPOFOL - GLOBAL BLOOD THERAPEUTICS INC's OXBRYTA, containing active ingredient VOXELOTOR Read More